Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Trump says Iranian 'fast-attack' ships that come close to US blockade will be eliminated
Former Brazil spy chief arrested by ICE in the United States
Deadline passes for US blockade of Iran's ports, Tehran threatens to retaliate
Israel presses assault on Lebanon border town ahead of US-hosted talks
Hungarian election winner Magyar vows to fight graft, change constitution
